Merck in China
TARGET: TEN BILLIONS
Merck’s second largest pharmaceutical production site is currently taking shape on the east coast of China, just around a two-hour drive away from Shanghai. When the factory reaches full capacity in 2021, plans call for the production of ten billion tablets a year in Nantong. The tablet presses required to achieve this come from Fette Compacting.
Press release, April 26, 2016
2020 STRATEGY: LMT GROUP TAKES DECISIVE STEPS
Corporate group achieves a new sales record with around 380 million euro in 2015. Continued strong growth planned until 2020 by means of focus and investments of 120 million euro. Fette Compacting Engineering Division taps new business areas. The LMT Tools Division is bundling its forces and setting up Competence Centers in core markets.
A PRODUCT WITHIN A PRODUCT: CROSS-CONTAMINATION AS A CHALLENGE FOR TABLETING
Pharmaceutical production increasingly involves the use of highly-active ingredients. This is also accompanied by increased demands on containment. Cross-contamination in particular becomes a risk for patient safety and product quality. But what requirements actually apply here and what technologies offer effective protection during tableting?
PHARMAMARKET 2020: UPSWING TURN FOR GLOBAL PRODUCTION
According to current studies, pharmaceutical producers can look forward to growing demand in the years to come. Growth means that more people receive access to medical care on the one hand while special medication for rare diseases gains in importance on the other. This increases international requirements on flexibility and quality in production.
Machine technology is obliged to offer the right solutions for each product and each requirement - increasingly in accordance with uniform global standards. In an interview, Rainer Krugmann, Global Director Sales at Fette Compacting, provides an outlook as to what trends Fette Compacting can anticipate in the production of solid formulations.
FAST, INDIVIDUAL, DIGITAL: WHAT CUSTOMERS EXPECT OF GLOBAL SUPPORT
Trade fairs such as the Interphex 2016 are more than mere platforms for presenting new machinery. They also offer the opportunity to exchange information with regard to current requirements on technical support and consulting. In New York City, Fette Compacting will be availing of the opportunity to interact with American and international pharmaceutical customers in order to find out what they expect of a machine manufacturer: from individual service through around-the-clock availability to secure digital networking. Insights into this issue are provided by Lars Plüschau, Director Global Customer Support.
IN THE LAND OF INNOVATIONS: SUBSIDIARY OPENS IN SWITZERLAND
Switzerland is the international leader when it comes to innovation and exports in the pharmaceutical industry. With the aim of guaranteeing pharmaceutical companies even faster technical service on site, a subsidiary of Fette Compacting opened in Basel on May 1, 2015.
ANNIVERSARY: TEN YEARS IN NANJING
In October 2014 the LMT Group celebrated the tenth anniversary of its subsidiary Fette Compacting Nanjing. More than 250 guests and 120 staff accepted the invitation. On this occasion, managing director Olaf J. Müller gave the go-ahead for the LMT Group Academy China and informed the visitors about the company's plans for a new building.
US PHARMACEUTICAL COMPANY USES PMAX TO INCREASE THE EFFICIENCY IN THE PRODUCTION
Using a Pmax turret with segment technology allows significantly more punches to be integrated than with conventional die tables. This is made possible by the FS12 punches which, with a shaft diameter of only twelve millimeters, do not require such a large spacing between the holes. The benefit of the punches can be seen in the production department at Amneal Pharmaceuticals in the USA.
GLOBAL , FLEXIBLE AND LEAN: TRENDS IN PHARMACEUTICAL PRODUCTION
Dr. Christoph Ebensperger, Head of Business Segment Life Sciences Horvath & Partners Germany, analyzes the current trends moving the pharmaceutical industry.
FROM THE WORLD OF GLOBAL CUSTOMER SUPPORT (PART 2): SEARCHING FOR CLUES
High-quality spare parts safeguard efficiency and process reliability over the entire life cycle of a plant. Fette Compacting exclusively supplies uses OEM (Original Equipment Manufacturer) products for international support with spare parts. The qualitative differences which can arise between original and generic parts are shown by two scientific studies using compression rollers as an example.
FE75 IN BRAZIL
Brazil has become a significant growth driver for the pharma industry: rising prosperity there is steadily increasing the demand for high-value medicines. That’s why Fette Compacting’s new FE75 tablet press had to be presented at FCE Pharma, the industry’s main fair in Latin America. As a result, its presentation from Interpack was shown to the FCE trade show in Brazil.
FDA WARNING LETTER: ENSURING OPTIMUM USE OF TABLET PRESSES
The US Food and Drug Administration (FDA) attracted considerable attention when it sent a Warning Letter that raised questions about why so many out-of-specification tablets are still distributed despite strict regulations and modern technology. In a White Paper Fette Compacting investigates the possible causes and offers advice on the optimum use of tablet presses.
PROF. DR. STEFFENS: "PHARMACEUTICAL COMPANIES SHOULD INVEST IN QUALITY"
The changes in the pharmaceutical market have an impact on the engineering industry. The manufacturers of the equipment used in pharmaceutical production are no longer just “machine fitters”, but are involved in the design of the process from the very start. Prof. Dr. Klaus-Jürgen Steffens comments on the future challenges in the engineering industry.
DR. SCHMIDT-BADER: "CONTINUOUS PROCESSES ARE THE FUTURE OF PRODUCTION"
The cost pressure in health care, rising demands of patients and rising costs in the development of new drugs influence the pharma production. Dr. Torsten Schmidt-Bader answers questions in regard to future challenges for the pharmaceutical industry and trends in production.
Excellence United Service
EXCELLENCE UNITED SERVICE - REACHABLE AROUND THE CLOCK
Pharmaceutical companies need to constantly increase production efficiency – every hour counts. The failure of a key machine can be a major disaster for production managers. Being able to reach the manufacturer’s technical support as soon as possible is therefore crucial when a breakdown occurs.
ULF SCHRADER:"PHARMA INDUSTRY AT CROSS-ROADS"
In recent years, the Pharma industry has found itself at cross-roads, its base of renewal eroding fast in the face of several major challenges. In parallel to these challenges however, new opportunities have emerged for the industry: new markets and consumers, new technologies, and more efficient operations. Ulf Schrader of McKinsey examines and evaluates this situation.